未登录

L

Lorenzo Nesti

university of pisa

H指数:21

被引数:1,577

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Wearable Cardioverter-Defibrillator in Patients at Transient Risk of Sudden Cardiac Death: State of the Art and Contemporary Clinical Evidence

可穿戴心脏复律除颤器在暂时性猝死风险患者中的应用：最新进展和当代临床证据

IF3.3

2026-09-160

OA

Oral glucose absorption is enhanced in early metabolic dysfunction-associated steatotic liver disease

早期代谢功能障碍相关脂肪性肝病患者口服葡萄糖吸收增强

IF10.2

2026-04-210

OA

Exercise Metabolic Flexibility in Type 2 Diabetes Treated With Empagliflozin: An Exploratory Analysis of the Randomised Trial EMPA-HEART

2型糖尿病中经艾美格列净治疗的运动代谢灵活性：EMPA-HEART随机试验的探索性分析

diabetes, obesity and metabolism

IF0

2026-03-310

PRE

Impact of Empagliflozin and Dapagliflozin on Sudden Cardiac Death: A Systematic Review and Meta-Analysis of Adjudicated Randomized Evidence

恩格列净和达格列净对心源性猝死的影响：一项对裁定随机证据的系统评价和荟萃分析

IF5.7

2025-09-170

PRE

Postprandial hypoglycaemia after gastric bypass in type 2 diabetes: pathophysiological mechanisms and clinical implications

IF10.2

2024-11-290

PRE

Circadian heart rate fluctuations predict 21-year cardiovascular and all-cause mortality in type 2 and type 1 diabetes

EUROPEAN HEART JOURNAL

IF35.6

2024-10-280

PRE

Antibiotic Prophylaxis and Treatment for Cardiac Device Infections

ANTIBIOTICS-BASEL

IF4.6

2024-10-180

OA

Circadian heart rate fluctuations predict cardiovascular and all-cause mortality in type 2 and type 1 diabetes: a 21-year retrospective longitudinal study

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY

IF7.5

2024-09-260

PRE

Cardioprotective effects of glucagon-like peptide 1 receptor agonists in heart failure: Myth or truth?

WORLD JOURNAL OF DIABETES

IF4.6

2024-05-151

OAAI

AORTIC STENOSIS AND HEART FAILURE: DIFFERENCES AND SIMILARITIES BEYOND PRESERVED EJECTION FRACTION

JOURNAL OF HYPERTENSION

IF4.1

2024-05-010

OA

Early time-restricted carbohydrate consumption vs conventional dieting in type 2 diabetes: a randomised controlled trial

IF10.2

2023-11-164

OAAI

Distinct effects of type 2 diabetes and obesity on cardiopulmonary performance

DIABETES OBESITY & METABOLISM

IF5.7

2023-10-124

OA

Haemodynamic and metabolic phenotyping of patients with aortic stenosis and preserved ejection fraction: a specific phenotype of heart failure with preserved ejection fraction?

EUROPEAN JOURNAL OF HEART FAILURE

IF10.8

2023-09-148

PRE

At any Level of Adiposity, Relatively Elevated Leptin Concentrations Are Associated With Decreased Insulin Sensitivity

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IF5.1

2023-08-312

PRE

Proatherogenic changes in lipoprotein particles associated with a high triglyceride to high-density lipoprotein cholesterol ratio in youths

IF4.7

2023-05-252

OAAI

Glomerular Hyperfiltration Predicts Kidney Function Decline and Mortality in Type 1 and Type 2 Diabetes: A 21-Year Longitudinal Study

IF16.6

2023-02-1418

OAAI

Synergistic effect of chronic kidney disease, neuropathy, and retinopathy on all-cause mortality in type 1 and type 2 diabetes: a 21-year longitudinal study

CARDIOVASCULAR DIABETOLOGY

IF10.6

2022-11-0517

OAAI

Epicardial adipose tissue thickness is associated with reduced peak oxygen consumption and systolic reserve in patients with type 2 diabetes and normal heart function

DIABETES OBESITY & METABOLISM

IF5.7

2022-09-2725

OAAI

Effect of empagliflozin on left ventricular contractility and peak oxygen uptake in subjects with type 2 diabetes without heart disease: results of the EMPA-HEART trial

CARDIOVASCULAR DIABETOLOGY

IF10.6

2022-09-1215

OAAI

Prognostic value of 24-hour ambulatory blood pressure patterns in diabetes: A 21-year longitudinal study

DIABETES OBESITY & METABOLISM

IF5.7

2022-06-298

OAAI